PREP in Neurodegenerative Disorders
Stopping Alzheimer's and Parkinson's disease
We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop the neuronal death in Alzheimer's and Parkinson's diseases.
Recent news from PREP lab
PREP lab in AD/PD 2019 meeting
PI of PREP lab, Dr. Timo Myöhänen, will be attending to AD/PD2019 meeting in Lisbon, Portugal.
Neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are progressive diseases where neuronal death in brain causes...
We are happy to share our research results. If you are interested in our publications but cannot find a copy, please do not hesitate to...
We are a dynamic group of researchers with a strong focus on finding novel disease modifying therapies for neurodegerative diseases...